ASRT vs QCOM · rev $125.0M vs P/E 16, rev $44.28B
Assertio Therapeutics Inc (ASRT) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
ASRT currently screens at market cap $151.5M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the ASRT and QCOM stock pages for the full models.
Not investment advice.